- New global coronavirus cases are continuing to trend down with most regions seeing a flat or falling trend. This includes the US where new cases in the South and West are continuing to fall. The decline in new cases in South America and Africa suggests Delta may not have been as contagious as first estimated.
Source: ourworldindata.org, AMP Capital
- In a potential breakthrough, a new Merck drug that reduced the risk of coronavirus hospitalisation and death in clinical trials by 50% holds out the promise of further beating back COVID. Meanwhile, vaccines are continuing help prevent serious illness. Hospitalisations and deaths remain subdued compared to previous waves in Europe and the UK. Deaths in the UK (red line in the next chart) are running at less than 20% of the level that might have been expected on the basis of the last wave (dashed line). And Israel is seeing a slowing in new cases, hospitalisations and deaths, helped by booster shots.
Source: ourworldindata.org, AMP Capital
- 47% of people globally and 72% in developed countries have now had at least one dose of vaccine.
Source: ourworldindata.org, AMP Capital
- The key risks to watch out for are:
-
- a renewed spike in cases in developed countries into the northern winter as recently seen in Israel and Singapore which highlights the need for very high vaccination rates, booster shots and possibly some ongoing restrictions to prevent too many getting coronavirus at once;
-
- the low coverage in poor countries; and
-
- the risk of more deadly/more transmissible mutations.
- While new cases are falling in NSW, they have surged in Victoria risking a delay in reopening and new cases are threatening a snap lockdown in Queensland.
Source: covid19data.com.au, AMP Capital
- The good news is that 63% of Australia’s whole population has now had at least one vaccine dose and in NSW its now 70%. The next chart shows a projection of when NSW, Victoria and Australia will meet adult vaccination targets for one dose based on an extrapolation of vaccination rates seen in the last 7 days. For first doses, NSW is through 80% and will reach 90% around 7th October, Victoria is now through 80% and Australia is through 70% & will reach 80% on 5th October.
Source: covid19data.com.au, AMP Capital
- On the basis of this projection the following table shows roughly when double dose vaccination target dates will be met based on the current lag between 1st and 2nd doses. NSW will hit the 70% of adults target around 5th October, Victoria around 29th October and Australia on average around 24th October. At the current rate Australia could hit 80% of the whole population fully vaccinated by 17th December – which is nearer to what we should ideally be aiming for, given the risks.
* Current gap in days between 1st and 2nd doses. Source: AMP Capital
- NSW is on track to “start” reopening on 11th October, Victoria in late October/early November (cases permitting) and the ACT (not shown) by mid-October. However, as the experience in Singapore (that has seen new cases surge to around 2000 a day) and Israel has shown, the key is that the reopening is gradual until even higher vaccination rates are met and so new cases can be spread over time so as to avoid a sudden surge which overwhelms the hospital system necessitating a return to tougher restrictions which would result in a setback for the economy.
- Vaccination is continuing to help keep serious illness down. Coronavirus case data for NSW shows that the fully vaccinated make up a low proportion of hospitalisations. While 11% of covid deaths occurring amongst fully vaccinated people may seem concerning just bear in mind that about 80% of those most vulnerable to die from coronavirus are fully vaccinated.
Source: NSW Health, AMP Capital
- The level of deaths (the red line in the next chart) is running at around 20% of the level predicted on the basis of the previous wave (dashed line). That means the vaccines are helping save roughly 50 lives a day at present.
Source: ourworldindata.org, covid19data.com.au, AMP Capital
|